Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease. - Zesiewicz,T.A.; Sullivan,K.L.; Maldonado,J.L.; Tatum,W.O.; Hauser,R.A. (Mov Disord, 2005)